Abstract
P-950 Combined antisense chemoradioimmunotherapy consistingof anti-HER2 scFv linked onto high energy radioisotopes, vinorelbine and 21-nucleotide double stranded siRNA targeted to DNMT1 induce PCD in metastatic NSCLC characterised by hypermethylated oncosuppressor p16 promoter CpG islands and overexpression of oncogenes cdc25c, Raf-1, HER-2 and bcl-2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
